Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Correcting vitamin D and progesterone deficiencies can significantly improve hair loss, acne, and BPH symptoms.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

Progesterone increases alcohol tolerance and withdrawal anxiety, while DHEAS prevents them.

The hormonal contraceptive combination effectively reduces androgen excess and improves PCOS symptoms like acne, hair loss, and menstrual issues.

Hormone levels in hair change during pregnancy, with progesterone increasing significantly compared to non-pregnant women.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Higher 3α,5α-THP levels in the brain may reduce depression in pregnant rats.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Hormonal treatments affect cow fertility and early embryo development.

Cyproterone helps women with hair loss caused by genetics. More research is needed to confirm the best dose.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Finasteride safely reduces excessive hair growth in women.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.